首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Multilayers enzyme-coated carbon nanotubes as biolabel for ultrasensitive chemiluminescence immunoassay of cancer biomarker
【24h】

Multilayers enzyme-coated carbon nanotubes as biolabel for ultrasensitive chemiluminescence immunoassay of cancer biomarker

机译:多层酶涂碳纳米管作为生物标记物用于癌症生物标记物的超灵敏化学发光免疫测定

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A novel and ultrasensitive chemiluminescence immunoassay (CLIA) method based on multiple enzyme layers assembled multiwall carbon nanotubes (MWCNTs) as signal amplification labels was developed by employing luminol-H2O2-HRP-bromophenol blue (BPB) enhanced chemiluminescence (CL) system for the detection of a cancer biomarker in human serum samples, as exemplified by the measurement of alpha-fetoprotein (AFP) as a model protein. In this study, horseradish peroxidase (HRP) was assembled onto MWCNTs templates layer-by-layer (LBL) through electrostatic interactions with polyion PDDA, and further conjugated with AFP secondary antibodies (Ab(2)) as the enzyme label. The resulting LBI. assembly could maximize the ratio of HRP/Ab(2) which Could amplify the sensitivity greatly. To the best of our knowledge, it was the first time for this strategy applied in CLIA to date. Under the optimum conditions of luminol-H2O2-HRP-BPB CL system and the sandwich immunoreactions, a linear range from 0.02 to 2.0 ng/mL (R=0.9980) was obtained with the detection limit of 8.0 pg/mL (3 sigma) which was two orders of magnitude lower than standard ELISA method. Furthermore, accurate detection of AFP in human Serum samples was also demonstrated by comparison to ELISA assays. From the above results, such signal amplification strategy proposed by the novel CNT-LBL enzyme label showed all excellent promise for ultrasensitive detection of cancer biomarkers in clinical laboratory.
机译:利用鲁米诺-H2O2-HRP-溴酚蓝(BPB)增强化学发光(CL)系统开发了一种基于多酶层组装多壁碳纳米管(MWCNT)作为信号放大标记的新型超灵敏化学发光免疫分析法(CLIA)。人血清样品中癌症生物标志物的检测,如作为模型蛋白的甲胎蛋白(AFP)的测量所举例说明的。在这项研究中,辣根过氧化物酶(HRP)通过与聚离子PDDA的静电相互作用逐层组装到MWCNTs模板上,并进一步与AFP二抗(Ab(2))偶联作为酶标记。产生的LBI。组装可以使HRP / Ab(2)的比例最大化,从而可以大大提高灵敏度。据我们所知,这是迄今为止在CLIA中首次应用此策略。在luminol-H2O2-HRP-BPB CL系统和三明治免疫反应的最佳条件下,线性范围为0.02至2.0 ng / mL(R = 0.9980),检出限为8.0 pg / mL(3 sigma),其中比标准ELISA方法低两个数量级。此外,还通过与ELISA测定法的比较证明了对人血清样品中AFP的准确检测。从以上结果可以看出,新型CNT-LBL酶标记物提出的这种信号放大策略显示了在临床实验室中超灵敏检测癌症生物标记物的所有极好的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号